Gilead Sciences (GILD ... shows that these estimate changes are directly correlated with near-term stockprices. To capitalize on this, we've crafted the Zacks Rank, a unique model that ...
Twice-yearly lenacapavir also demonstrated sup Gileadstock popped Thursday after the biotech giant said its twice-yearly shot prevented 99.9% of HIV infections in a study. Gilead Sciences rose ...
Yee notes that while Gilead's stock has not moved much over the last few years, it will likely take off as it moves forward with its new HIV prevention drug. "They have announced this week a ...
Some results have been hidden because they may be inaccessible to you